| 摘要 |
<p>The present invention relates to the use of VEGF antagonists and a novel anti-α5&bgr;1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5&bgr;1 antibodies and methods of making and using them.</p> |
